By expenditures
| Name | Title | Type |
|---|---|---|
| Andres Vives | CEO | Auditee |
| George Wilhelm | Interim Director of Finance | Auditee |
| Mary Mackrell | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 366080 | 2024 | 2025-09-11 | Lutz Selig & Zeronda CPAS LLP | $7.02M |
| 332989 | 2023 | 2024-12-17 | Lutz Selig & Zeronda CPAS LLP | $6.27M |
| 318778 | 2022 | 2024-09-09 | Lutz Selig & Zeronda CPAS LLP | $4.30M |
| 315018 | 2021 | 2024-07-12 | Lutz Selig & Zeronda CPAS LLP | $3.56M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 366080 | 2024 | 2025-09-11 | 1152608 | 2024-002 | Material Weakness | Yes | L |
| 366080 | 2024 | 2025-09-11 | 1152607 | 2024-001 | Material Weakness | - | C |
| 366080 | 2024 | 2025-09-11 | 576166 | 2024-002 | Material Weakness | Yes | L |
| 366080 | 2024 | 2025-09-11 | 576165 | 2024-001 | Material Weakness | - | C |
| 332989 | 2023 | 2024-12-17 | 1091065 | 2023-001 | - | Yes | A |
| 332989 | 2023 | 2024-12-17 | 1091064 | 2023-001 | - | Yes | A |
| 332989 | 2023 | 2024-12-17 | 1091063 | 2023-001 | - | Yes | A |
| 332989 | 2023 | 2024-12-17 | 514623 | 2023-001 | - | Yes | A |
| 332989 | 2023 | 2024-12-17 | 514622 | 2023-001 | - | Yes | A |
| 332989 | 2023 | 2024-12-17 | 514621 | 2023-001 | - | Yes | A |
| 318778 | 2022 | 2024-09-09 | 1062578 | 2022-001 | - | Yes | L |
| 318778 | 2022 | 2024-09-09 | 1062577 | 2022-001 | - | Yes | L |
| 318778 | 2022 | 2024-09-09 | 1062576 | 2022-001 | - | Yes | L |
| 318778 | 2022 | 2024-09-09 | 486136 | 2022-001 | - | Yes | L |
| 318778 | 2022 | 2024-09-09 | 486135 | 2022-001 | - | Yes | L |
| 318778 | 2022 | 2024-09-09 | 486134 | 2022-001 | - | Yes | L |
| 315018 | 2021 | 2024-07-12 | 1054802 | 2021-001 | Significant Deficiency | - | A |
| 315018 | 2021 | 2024-07-12 | 1054801 | 2021-001 | Significant Deficiency | - | A |
| 315018 | 2021 | 2024-07-12 | 478360 | 2021-001 | Significant Deficiency | - | A |
| 315018 | 2021 | 2024-07-12 | 478359 | 2021-001 | Significant Deficiency | - | A |